GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.1297
-0.0039 (-2.92%)
At close: May 30, 2025, 4:00 PM
0.1257
-0.0040 (-3.08%)
After-hours: May 30, 2025, 7:55 PM EDT
GlucoTrack Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
3.71M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
GCTK News
- 3 days ago - Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD - GlobeNewsWire
- 11 days ago - Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development - GlobeNewsWire
- 17 days ago - Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 18 days ago - Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor - GlobeNewsWire
- 6 weeks ago - Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas - GlobeNewsWire
- 2 months ago - Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor - GlobeNewsWire
- 2 months ago - Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 2 months ago - Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes - GlobeNewsWire